Current pharmacotherapy for hepatitis B infection

Author： Galan Mark V   Gordon Stuart C   Boyce Douglas  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.2, Iss.8, 2001-08, pp. : 1289-1298

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current pharmacotherapy for the treatment of chronic hepatitis B

By Lagget M   Rizzetto M  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 10, 2003-10 ,pp. : 1821-1827

Informa Healthcare

Access to resources Recommend Favorite

Current and Novel Therapies for Hepatitis B Virus Infection

By  

Mini Reviews in Medicinal Chemistry, Vol. 10, Iss. 1, 2010-01 ,pp. : 20-31

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacotherapy of chronic hepatitis C virus infection – the IDEAL trial: ‘2b or not 2b (= 2a), that is the question’

By Toyoda Hidenori   Kumada Takashi  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 17, 2009-12 ,pp. : 2845-2857

Informa Healthcare

Access to resources Recommend Favorite

Drug Delivery Systems and Liver Targeting for the Improved Pharmacotherapy of the Hepatitis B Virus (HBV) Infection

By Cuestas María   Mathet Verónica   Oubiña José   Sosnik Alejandro  

Pharmaceutical Research, Vol. 27, Iss. 7, 2010-07 ,pp. : 1184-1202

Springer Publishing Company

Access to resources Recommend Favorite

Haemophilia B: current pharmacotherapy and future directions

By Franchini Massimo   Frattini Francesco   Crestani Silvia   Bonfanti Carlo  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 14, 2012-10 ,pp. : 2053-2063

Informa Healthcare

Access to resources Recommend Favorite